MMP2 and melanoma: The synthetic strategy allowed to furnish a pool of peptidomimetics varying in the three key functional groups, and subsequent bioassays towards purified proteins and on a melanoma cell line allowed to identify a hydroxamic acid derivative capable of displaying dual activity towards MMP2 and αvβ3 RGD integrin.